Lympho Bob

This past Monday, I had the privilege of reading something I wrote to a small audience. I won 2nd prize in a memoir writing contest -- and a...

Hard to believe it's almost December. All of the signs are out there: 20 degree weather in Connecticut, Salvation Army bell ringers in f...

OK, another paper from ASH -- this one not focused on treatment, but on its long-term after effects. The paper is called " Psychosoci...

 Another interesting paper to be delivered at ASH in a few weeks: " Correlative Analysis and Clinical Update Of a Phase II Study Using ...

Another interesting abstract from ASH: " Frontline Rituximab Monotherapy Induction Versus a Watch and Wait Approach For Asymptomatic Ad...

A quick break from all of that good ASH Follicular Lymphoma news: Yesterday, the FDA announced that it has granted accelerated approval fo...

Sometimes ASH or ASCO or some other lymphoma-nerd conference is kind of a dud -- nothing really new or exciting to be discussed (at least, n...